Inventor · disambiguated record
Claudio Anasetti
Also filed as: ANASETTI CLAUDIO
7 granted patents·6 pending applications·552 citations·filing 1990–2025
83Inventor score
Files withH LEE MOFFITT CANCER CT & RES8CTI BIOPHARMA CORP2HUTCHINSON FRED CANCER RES1PROTEIN DESIGN LABS INC1
Top patents by PatentIndex Score
13 records- 0196US5834597AMutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the samePROTEIN DESIGN LABS INC·Filed 1996·Granted Nov 10, 1998·499 cites·18 claims
- 0281US10414810B2Double mutant survivin vaccineH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Sep 17, 2019·2 cites·10 claims
- 0380US2024368089A1Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 0478US12060332B2Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2023·Granted Aug 13, 2024·0 cites·3 claims
- 0573US12344642B2Variant survivin vaccine for treatment of myelomaH LEE MOFFITT CANCER CT & RES·Filed 2021·Granted Jul 1, 2025·0 cites·12 claims
- 0672US11149072B2Variant survivin vaccine for treatment of myelomaH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Oct 19, 2021·0 cites·19 claims
- 0772US5273738ARadiation delivery to lymphoid and marrow tissuesHUTCHINSON FRED CANCER RES·Filed 1990·Granted Dec 28, 1993·51 cites·14 claims
- 0871US2022281828A1Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 0968US2025179132A1Variant survivin vaccine for treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2025·Application pending·0 cites
- 1063US11203576B2Aurora kinase and Janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Dec 21, 2021·0 cites·11 claims
- 1155US2021069199A1Methods of treating transplant rejectionCTI BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 1248US2018318306A1Methods of treating transplant rejectionCTI BIOPHARMA CORP·Filed 2016·Application pending·0 cites
- 1340US2002006403A1CD28-specific antibody compositions for use in methods of immunosuppressionFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Claudio Anasetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →